Targeted drug delivery systems using nanocarriers offer a versatile platform for breast cancer treatment; however. a robust. CD44-targeted niosomal formulation has not been developed and deeply studied (both in vitro and in vivo) yet. Here. https://darthomes.shop/product-category/mirror/